Drug discovery

#Autoimmune disease #Diabetes #Drug discovery

Australian discovery boosts hopes of preventing Type 1 diabetes

Australian researchers based may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold. Mater Research and University of Queensland researchers have developed a biological agent, sRAGE, that boosts white blood cell function which is damaged in… Read More

#Editor's Choice #News #Trending News

Team of scientists working in a lab
#Cell and protein analysis #Drug discovery #Mass spectrometry / NMR

Native mass spectrometry: Drug discovery’s new kid on the block

Listen to this article on the DDW Podcast: By Idlir Liko, Kleitos Sokratous & Miguel Silva at OMass Therapeutics Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s work, including her recent publication in Nature, highlights… Read More

#Exclusive Content

Psilocybin
#Biologics / Biotechnology #Drug discovery #Psychedelics

How this biotech is ramping up its psychedelic drug discovery

Psychedelic plants and fungi have been used medicinally by indigenous populations over thousands of years. But while psychedelic drug research has witnessed a relative roller-coaster ride of effort since the mid-20th century, more recent interest in the use of psychedelics for treating mental health and psychiatric disorders has spurred… Read More

#Exclusive Content

#Covid-19 #DNA #Drug discovery #Genomics #Infectious diseases

This week in drug discovery (18 -22 July)

News round-up by DDW’s Reece Armstrong for 18 – 22 July Covid-19 vaccines remain effective six months after second dose  Two doses of Covid-19 vaccines were sufficient in providing protection against severe cases of the infectious disease, according to new research.   New combination therapy… Read More

#News

#Antibodies #Drug discovery #Drug screening

Carterra joins TetraScience Network to boost antibody services  

Life sciences company Carterra has joined data cloud company TetraScience’s network of partners to help generate insights into the potential of antibodies as drug candidates.  The Tetra Partner Network (TPN) is an ecosystem of partners which connects R&D data for pharmaceutical and biopharmaceutical customers.   Carterra… Read More

#News

#Drug discovery #Drug screening #Lead optimisation

One stop for GPCR Drug Discovery Needs

This paid-for advertorial by Eurofins Discovery appeared in Volume 23 – Issue 3, Summer 2022. In the following article, Luke Oostdyk, Lakshmi Anantharaman and Nicole Servant from Eurofins Discovery discuss how G-Protein Coupled Receptor screening and profiling can advance drug discovery programs.  The sheer number of understudied and orphan receptors in… Read More

#Exclusive Content #Intelligence

Neuron
#Clinical research #Drug discovery #Motor neurone disease

Project granted £4.25m to advance research in motor neurone disease 

Six UK universities have collectively received £4.25 million as part of a collaborative project aimed at finding new treatments for motor neurone disease (MND).  The MND Collaborative Partnership was launched by LifeArc, MND Association, MND Scotland and My Name’5 Doddie Foundation, alongside government bodies Medical Research Council… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Immunotherapy #Synthetic biology

The summer issue of Drug Discovery World magazine is out now 

Featuring Specialty Spotlight: Immunotherapy, the magazine is available to download and read for free on the DDW App. Key features of the summer issue include: Why immunocompromised people are ‘forgotten’: Championing female leaders across drug discovery and development: Improving quality control for CAR T cell therapies, plus exclusive interviews and articles on… Read More

#News #Trending News

#Drug discovery #ELRIG #Events #Pharmacology

Event: New modalities in pharmacology and drug discovery

On 4 and 5 July 2022, The British Pharmacological Society and ELRIG UK will explore new pharmacological modalities of differing mechanisms, shapes and sizes and how these are being translated to create patient benefit at the Francis Crick Institute in London, UK. This is both a free and in-person event. Read More

#News

#Diversity #Drug discovery #Pharma #Women in STEM

App exclusive: Women in STEM: how to promote diversity in pharma

In this article exclusive to the Drug Discovery World app, Reece Armstrong speaks to Anca Ciobanu, Consultant and Strategic Theme Lead at the Pistoia Alliance about its Women in STEM pilot programme and some of the barriers women face for progressing through the life sciences sector. The article touches upon… Read More

#Exclusive Content

#Appointment #Drug discovery

Metrion Biosciences continues expansion with new hire  

Metrion Biosciences has appointed a Head of European Business Development to support the next phase of the company’s ion channel drug discovery services.   The company has appointed Dr Benedetta Montagnini as Head of European Business Development in a move which follows the recent creation of a Client… Read More

#News

#Assays #Drug discovery #Multiplexing #Screening

What you need to know about multiplexing in drug discovery

Download this guide from Abcam to learn more about: How multiplexing generates more insightful data The key principles, benefits and limitations of different multiplex assays How to select the most suitable multiplex assay for your screening program Click here to download… Read More

#News

#CRISPR #CRISPR screening #CRISPR-Cas9 #Drug discovery

Exclusive CRISPR-Cas9 screening event

Join DDW, supported by Horizon Discovery for this exclusive free event which will examine CRISPR-Cas9 screening and how it offers a powerful approach to advancing drug discovery and the understanding of genetic disease. The event will take place on 9 June 2022, 3PM BST. Register for free here. Joanna… Read More

#News